The marijuana rescheduling hearing has just ended and now the FDA Schedules Psychedelics Hearing, amid a push for medical approval after President Donald Trump’s executive order fast-tracking access to psychedelics for mental health conditions and substance use disorder. The FDA published final clinical guidance for developers preparing to submit investigational new drug applications.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
